This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Autosomal Dominant Emery-dreifuss Muscular Dystrophy (disorder)
Information about Autosomal Dominant Emery-dreifuss Muscular Dystrophy (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Autosomal Dominant Emery-dreifuss Muscular Dystrophy (disorder)
Most recent studies have shown that Autosomal Dominant Emery-dreifuss Muscular Dystrophy (disorder) shares some biological mechanisms with acquired-partial-lipodystrophy, atrophy, cardiomyopathies, cardiomyopathy-dilated, congenital-muscular-dystrophy-(disorder), dystrophy, familial-partial-lipodystrophy, heart-diseases, lipodystrophy, muscle-contracture, muscle-weakness, muscular-atrophy, muscular-dystrophies-limb-girdle, muscular-dystrophy, muscular-dystrophy-emery-dreifuss, myopathy, neuromuscular-diseases, weakness, x-linked-emery-dreifuss-muscular-dystrophy.
Among the many pathways, these few ones have gauged particular interests from scientists studying Autosomal Dominant Emery-dreifuss Muscular Dystrophy (disorder), and have been seen in publications frequently: Aging, Cardiac Conduction, Cell Cycle, Cell Death, Cell Division, Chromatin Organization, Dna Methylation, Hypersensitivity, Innervation, Interphase, Localization, Locomotion, Methylation, Myoblast Differentiation, Nuclear Envelope Reassembly, Pathogenesis, Regeneration, Senescence, Translation
Quite a number of genes have been found to play important roles in Autosomal Dominant Emery-dreifuss Muscular Dystrophy (disorder), such as ACE, DES, DMD, DNASE1, EMD, EP300, FKRP, GDI1, INS, LMNA, LMNB1, LMNB2, MTSS1, MYOD1, MYOG, RB1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.